study
-
Spine
DiscGenics Announces Positive Two-Year Clinical Data from Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease
Discogenic progenitor cell therapy safely increased disc volume and provided rapid, durable improvements in low back pain, function, quality of…
Read More » -
Extremities
UAT Group Subsidiary, Ossifix Orthopedics Begins Comparative Study
Tampa, FL, Jan. 20, 2023 (GLOBE NEWSWIRE) — Umbra Applied Technologies Group, Inc. (OTC Pink: UATG) (UAT Group) announce today…
Read More » -
Recon
Hip Innovation Technology Announces Initiation of FDA Approved Investigational Device Exemption Study
First U.S. Implantation of its Reverse Hip Replacement System for the Treatment of Total Hip Arthroplasty Completed BOCA RATON, Fla., Jan.…
Read More » -
Spine
Karolinska Development’s portfolio company OssDsign has published a case report from the TOP FUSION study in a scientific journal
STOCKHOLM, SWEDEN, January 4, 2023 – Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company OssDsign has published…
Read More » -
Hospitals
New Study from University Hospitals Shows Time-Saving Advantage of ArthroFree™ Wireless Arthroscopic Camera
The study is part of a broader collaboration between Lazurite and University Hospitals (UH) Ventures CLEVELAND, December 12, 2022 /OrthoSpineNews/…
Read More » -
Spine
New Publication Supports Clinical Effectiveness of Centinel Spine’s Stand-Alone STALIF® M Integrated Interbody™ Portfolio
Study conducted by the Texas Back Institute (TBI), Plano, TX and published in the International Journal of Spine SurgeryThe retrospective study supports utilizing STALIF…
Read More » -
Neuro
Mainstay Medical announces the release of post-marketing data from the ongoing ReActiv8®-C study in patients with chronic low back pain
New real-world findings support the effectiveness and use of ReActiv8® Restorative Neurostimulation™ to treat intractable chronic low back pain November…
Read More » -
Recon
Study aims to improve diagnosis of infections following shoulder surgery
UTSW researchers joined colleagues at 11 hospitals to examine infections after arthroplasty revisions. DALLAS – November 2, 2022 /OrthoSpineNews/– The…
Read More » -
Neuro
Mainstay Medical Announces Publication of Three-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™
Data continue to show compelling efficacy and safety, including improvement on all key measures of pain and disability, as compared…
Read More » -
Biologics
Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine® Study
–Two-Year Follow-Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients who Underwent the StemSpine® Procedure for Treating…
Read More » -
Sports Medicine
Moximed’s MISHA™ Knee System Achieves Superiority of Primary Endpoint in Pivotal Study
Implantable shock absorber demonstrates clinically meaningful pain relief and functional improvement in data presented at OSET September 23, 2022 FREMONT,…
Read More » -
Biologics
Innovative Spinal Biomaterial Demonstrates Early Healing in Retrospective Study
ZFUZE Shows 91.4% Fusion Rates at 8 Months AUSTIN, Texas, Sept. 08, 2022 (GLOBE NEWSWIRE) — DiFusion, Inc., an Austin,…
Read More » -
Spine
Premia Spine’s TOPS™ Spinal Joint Replacement Shows Potential to Relieve Back Pain and Maintain Mobility Without Adjacent Level Degeneration
Case series published in Operative Neurosurgery evaluates long-term data on motion-preserving alternative to fusion. September 7, 2022 NORWALK, Conn.–(BUSINESS WIRE)–Premia…
Read More » -
Recon
Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Femoral Nerve Block in the Adductor Canal for Total Knee Arthroplasty
Study achieved primary and key secondary endpoints of statistically significant reductions in postsurgical pain and opioid consumption through 96 hours.…
Read More » -
Recon
Knee Arthroplasty Market Is Likely to Reach USD 13928.96 million with Growing CAGR Of 6.00% forecast By 2029
Patients are becoming more aware of the advantages of surgery over alternative forms of treatment including medication and physical therapy,…
Read More »